| YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW Patent applications |
| Patent application number | Title | Published |
|---|
| 20110178151 | COMPOUNDS AND METHODS OF TREATING OBESITY - The present invention relates to novel fatty acid derivatives, methods for their preparation, pharmaceutical compositions including such compounds, and methods of using these compounds and compositions, especially as agents for the treatment of obesity and related disorders, and for improving cognition. | 07-21-2011 |
| 20100319091 | METHODS OF MODULATING PRODUCTION OF PHENYLPROPANOID COMPOUNDS IN PLANTS - A method of enhancing production of a phenylpropanoid compound in a plant or plant cell is disclosed. The method comprising: (a) expressing in the plant or plant cell a heterologous polynucleotide which produces a myb gene of the phenylpropanoid pathway; and (b) contacting the plant or plant cell with at least one substrate of the phenylpropanoid pathway, the substrate being upstream to the production of the phenylpropanoid compound, thereby enhancing the production of a phenylpropanoid compound in the plant or plant cell. | 12-16-2010 |
| 20100218645 | METHOD OF REMOVAL OF HEAVY METAL IONS FROM WATER - A method for removal of heavy metal ions from water including submerging an aquatic plant or dried material thereof in said water and subsequently irradiating the water in which the aquatic plant or dried material has been submerged with microwave irradiation. | 09-02-2010 |
| 20100216868 | AGENTS, COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIES IN WHICH REGULATING AN ACHE-ASSOCIATED BIOLOGICAL PATHWAY IS BENEFICIAL - The present invention provides agents which are capable of regulating the function of a micro-RNA component which can be used to regulate an AChE-associated biological pathway. In addition, the present invention provides methods and pharmaceutical compositions for the treatment of various pathologies related to AChE-associated biological pathways such as apoptosis, aberrant cholinergic signaling, abnormal hematopoietic proliferation and/or differentiation, cellular stress, exposure to inflammatory response-inducing agents, and/or exposure to organophosphates or other AChE inhibitors. | 08-26-2010 |
| 20100071088 | Plant Expression Constructs and Methods of Utilizing Same - A Geminivirus based expression construct being capable of systemic symptomeless spread in a plant host is provided as well as methods of utilizing same for plant gene expression, gene silencing and plant protection. | 03-18-2010 |
| 20100040340 | Electro-Optic Crystal-Based Structures and Method of Their Fabrication - A structure is presented for use in optic and electro-optic devices. The structure comprises at least one region of an amorphous KLTN-based material in a KLTN-based material. Also provided is a method of processing a KLTN-based material, comprising at least one of the following: bombarding said KLTN-based material with light ions: and etching said KLTN-based material when in amorphous state by an acid; thereby allowing fabrication of one or more optical components within the KLTN-based material. | 02-18-2010 |
| 20090061226 | SPHERICAL COMPOSITES ENTRAPPING NANOPARTICLES, PROCESSES OF PREPARING SAME AND USES THEREOF - Novel nanoparticles-entrapping spherical composites, composed of a metal oxide or semi-metal oxide and a hydrophobic polymer, are disclosed. The spherical composites are characterized by well-defined spherical shape, a narrow size distribution and high compatibility with various types of nanoparticles. Further disclosed are processes for preparing the nanoparticles-entrapping spherical composites and uses thereof. | 03-05-2009 |
| 20080275135 | Resorcinol Derivatives and Their Use for Lowering Blood Pressure - Disclosed are synthetic cannabinoids, namely resorcinol derivatives, which reduce blood pressure without having psychotropic effects. Pharmaceutical compositions for the treatment of high blood pressure related conditions, as well as methods of treating the same utilizing as active agent the compounds of the invention are also disclosed herein. Preferred active compounds are those which bear a long side chain on the C | 11-06-2008 |
